|
🐜
|
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
106 auth.
E. Cohen,
D. Soulières,
C. Tourneau,
J. Dinis,
L. Licitra,
M. Ahn,
A. Soria,
J. Machiels,
N. Mach,
R. Mehra,
B. Burtness,
Pingye Zhang,
Jonathan C Cheng,
R. Swaby,
K. Harrington,
...
M. Acosta-Rivera,
D. Adkins,
M. Aghmesheh,
M. Airoldi,
E. Aleknavičius,
Y. Al-farhat,
A. Algazi,
S. Almokadem,
A. Alyasova,
J. Bauman,
M. Benasso,
A. Berrocal,
V. Bray,
B. Burtness,
F. Caponigro,
A. Castro,
T. Cescon,
Kelvin K. W. Chan,
A. Chaudhry,
B. Chauffert,
E. Cohen,
T. Csőszi,
J. Boer,
J. Delord,
A. Dietz,
J. Dinis,
C. Dupuis,
L. Digue,
J. Erfán,
Y. E. Álvarez,
M. Evans,
M. Fidler,
M. Forster,
S. Friesland,
A. Ganti,
L. Geoffrois,
C. Grant,
V. Gruenwald,
K. Harrington,
T. Hoffmann,
G. Horvai,
A. Inčiūra,
R. Jang,
P. Jankowska,
A. Jimeno,
M. Joseph,
A. Ramiro,
B. Karaszewska,
A. Kawecki,
U. Keilholz,
U. Keller,
Sung-Bae Kim,
J. Kocsis,
N. Kotecki,
M. Kozloff,
J. Lambea,
L. Landherr,
Yuri Lantsukhay,
S. Lazarev,
Lip W Lee,
Igor Lifirenko,
D. Martincic,
O. V. Matorin,
M. McGrath,
K. Misiukiewicz,
J. Morris,
F. F. Mufazalov,
J. Niu,
D. Srinivasan,
P. Segura,
D. Rauch,
Maria Leonor Ribeiro,
C. Rodriguez,
F. Rolland,
A. Russo,
Á. Ruzsa,
Frederico Sanches,
S. Shin,
Mikhail Shtiveland,
D. Soulières,
P. Specenier,
É. Szekanecz,
J. Szota,
C. Herpen,
Héctor A. Vélez‐Cortés,
W. Walsh,
S. Wilop,
R. Winterhalder,
M. Wojtukiewicz,
D. Wong,
D. Zandberg
|
10 |
2019 |
10
🐜
|
|
🐜
|
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
11 auth.
Dong-Wan Kim,
Dong-Wan Kim,
Si-Young Kim,
Hoon-Kyo Kim,
Sang We Kim,
S. Shin,
...
Jun Suk Kim,
Kwan Park,
M. Y. Lee,
D. Heo,
D. Heo
|
8 |
2007 |
8
🐜
|
|
🦁
|
Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
S. Shin
|
8 |
2018 |
8
🦁
|
|
🐜
|
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
17 auth.
Joon-Oh Park,
Sang-We Kim,
J. Ahn,
C. Suh,
Jung Shin Lee,
J. Jang,
E. Cho,
S. Yang,
Jin-Hyuk Choi,
D. Heo,
...
S. Park,
S. Shin,
M. Ahn,
J. Lee,
Y. Yun,
Jae-Won Lee,
Keunchil Park
|
7 |
2007 |
7
🐜
|
|
🦁
|
Hearing Loss in Adults.
S. Shin
|
7 |
2018 |
7
🦁
|
|
🐜
|
Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy
10 auth.
Dae-Ho Lee,
Keunchil Park,
J. Kim,
Jong-Seok Lee,
S. Shin,
Jin-Hyoung Kang,
...
M. Ahn,
J. Ahn,
C. Suh,
Sang-We Kim
|
7 |
2010 |
7
🐜
|
|
🐜
|
Paclitaxel, 5‐fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma
10 auth.
Yeul-Hong Kim,
S. Shin,
B. S. Kim,
Jin Kim,
J. G. Kim,
Y. Mok,
...
Chong‐Suk Kim,
Hosung Rhyu,
J. Hyun,
J. Kim
|
7 |
1999 |
7
🐜
|
|
🐜
|
Economic Burdens and Quality of Life of Family Caregivers of Cancer Patients
10 auth.
Y. Yun,
Youngsun Rhee,
Im-Ok Kang,
Jung Suk Lee,
S. Bang,
Won Sup Lee,
...
Jun Suk Kim,
S. Kim,
S. Shin,
Y. Hong
|
7 |
2005 |
7
🐜
|
|
🐜
|
Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer
10 auth.
S. Kim,
Hoiseon Jeong,
O. Woo,
J. Seo,
Aeree Kim,
E. Lee,
...
S. Shin,
Yeul-Hong Kim,
Jun Suk Kim,
K. Park
|
6 |
2013 |
6
🐜
|
|
🐜
|
Genotype–phenotype correlation in MYH9‐related thrombocytopenia
10 auth.
F. Dong,
Sufeng Li,
N. Pujol-Moix,
N. Luban,
S. Shin,
J. Seo,
...
A. Ruiz‐Saez,
J. Demeter,
S. Langdon,
M. Kelley
|
6 |
2005 |
6
🐜
|
|
🐜
|
Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival.
11 auth.
S. Kim,
I. Choi,
K. Park,
S. Yoon,
S. Oh,
J. Seo,
...
C. Choi,
B. Kim,
S. Shin,
Yeul-Hong Kim,
Jun Suk Kim
|
6 |
2004 |
6
🐜
|
